William Dolphin was appointed to the Avita Medical board on 5 March 2008 and then appointed as CEO July, serving until late 2013. He was previously CEO of Visiomed Group Limited. Dr Dolphin holds a PhD in biophysics obtained from Boston University in 1989. He held appointments as professor in the Departments of Bio-medical Engineering and Biology at Boston
University and served as president and chief technology officer of a US-based contract research and development company. Dr Dolphin was subsequently the president, CEO and chairman of a US medical device company. In 2003 he relocated to New Zealand and was CEO of a technology joint venture. Dr Dolphin has served as a director of numerous companies in the US, NZ and Australia, is the author of more than 60 peer-reviewed scientific articles, holds five US and international patents and was twice recipient of the National Research Service Award from the US National Institutes of Health.
